The WEB-RADR Team has published ‘Recommendations on the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR’ in Drug Safety.
Please click here for the paper: Recommendations on the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR
Key points:
|
General social media, as exemplified by sample data from Facebook and Twitter, are not recommended for broad statistical signal detection. |
|
Social media channels may provide a useful adjunct to pharmacovigilance activities in specific niche areas such as exposure during pregnancy and abuse/misuse of medicines. |
|
Future enhancement of adverse event recognition algorithms may broaden the scope and utility of social media over time. |